In-Depth Analysis of Xinhua Medical's "1-Yuan Sale" and the Collapse of Listed Companies' Hospital Investment Frenzy

Based on the searched information, I provide you with a detailed analysis report:

---

Xinhua Medical was founded in 1943 and listed in 2002, with core business covering

four segments [1]. As a state-owned enterprise with a long history in medical devices, the company once expanded aggressively in the medical services sector.

Time Node	Event Description
Before 2017	Xinhua Medical once acquired 18 hospitals , reaching the peak of its medical services footprint [1]
Starting from 2018	Problems emerged in some hospitals, and the company initiated the listing and transfer of hospitals [1]
2020	Successively sold equity in Zibo Zichuan District Hospital West Branch and Nanyang Orthopedics High-Tech Zone Hospital
August 2022	Transferred 12.85% equity in Shanghai Chenwei Zhongde Hospital, involving multiple orthopedic hospitals
April 2024	Xiangyin Huaya Hospital voluntarily applied for suspension of operations and was listed as a judgment debtor multiple times
January 2025	Listed 55% equity in Shandong Xinhua Changguo Hospital for transfer, with a base transfer price of RMB 113 million
August 21, 2025	Transferred 100% state-owned equity of Zibo Xinhua Hospital for RMB 200,000 on the Shandong Property Rights Exchange Center [1][2]
Current Status	Only 7 hospitals remain under its medical services segment, with approximately 11 sold or transferred from the peak [1]

• Registered Capital
  : Nearly RMB 10 million
• 2024 Operating Revenue
  : Only
  RMB 2,300
  (nearly zero)
• 2024 Net Profit
  :
  -RMB 12,600
• First Half of 2025 Loss
  :
  -RMB 897,800
• Evaluated Net Assets
  : RMB 65,000
• Listing Price
  : RMB 200,000
• Current Status
  : Established for over 20 years, but operations are almost stagnant [2]

---

Enterprise	Core Business	Entry Time	Current Status	Disposal Method
Yonghe Zhikong	Plumbing Equipment	2019	All 4 oncology hospitals are operating at a loss; 1 has negative net assets	No buyers even at a 90% discount; Dazhou Medical Oncology Hospital has been listed for price reduction 6 consecutive times [1]
Grand Orient (Dadongfang)	Conglomerate	2022	Jinhua Lianji Hospital accumulated losses of RMB 79.15 million over 4 years	Transferred 80% equity of Jinhua Lianji Hospital for RMB 1 in November 2025 [1]
Jimin Health	Large-Volume Infusion	2016	Performance fell short of expectations after acquiring multiple hospitals	Sold equity of acquired hospitals to recoup capital [1]
China Resources 999	Pharmaceutical Manufacturing	Early Stage	Medical services did not align with core business strategy	Transferred 82.89% equity of 999 Hospital in 2018 [1]
Guizhou Yibai Pharmaceutical	Pharmaceutical Manufacturing	Early Stage	Strategic adjustment	Transferred equity of Huainan Chaoyang Hospital for RMB 660 million in 2018 [1]
Genview Pharmaceutical	Pharmaceutical Manufacturing	Early Stage	Focused on core business	Transferred Chengdu Jinsha Hospital for RMB 150 million in 2018 [1]
Changbao Co., Ltd.	Energy Machinery	2017	Acquired medical assets for RMB 992 million, but less than 2 years later	Announced the divestment of 3 hospital assets in 2024 [1]
Humanwell Healthcare	Pharmaceutical Manufacturing	2014	Originally planned to establish 20 hospitals	Gradually exited the medical services sector starting from 2018 [1]

---

┌─────────────────────────────────────────────────────────────────┐
│                        Core Conflict                             │
├─────────────────────────────────────────────────────────────────┤
│  Attributes of Hospital Investment  vs  Capital Demands of Listed Companies │
├─────────────────────────────────────────────────────────────────┤
│  • Long payback period (5-10 years)  •  Short-term performance growth requirements │
│  • Heavy asset investment           •  Quick capital recovery          │
│  • High barriers to professional management • Diversified expansion logic │
│  • Stable but slow cash flow        •  High-leverage acquisition model │
└─────────────────────────────────────────────────────────────────┘

Policy Factor	Impact Analysis
Medical Insurance Fee Control	DRG/DIP payment reforms have compressed profit margins, restricting hospital revenue [3]
Centralized Drug Procurement	The “drug-reliant hospital operation model” has ended, depriving private hospitals of a key profit source [3]
Stricter Medical Insurance Supervision	The cost of non-compliance has risen sharply, increasing compliance pressure [4]
Reduction in Fiscal Subsidies	National health expenditure decreased by 9.1% year-on-year in 2024 [3]
Adjustment to Private Medical Care Policies	Policy dividends are gradually fading [1]

According to statistical data,

, a 58% decrease from the peak in 2016 [5]:

• Obstetrics and gynecology hospitals are the first to be hit
  : A well-known obstetrics and gynecology hospital in Beijing saw its delivery volume drop from 6,000 cases in 2017 to 2,000 cases in 2023, with
  delivery room vacancy rate exceeding 60%
  [5]
• Imbalanced population flow
  : A prefecture-level city in Northeast China saw over 10% of its population outflow in the past five years, causing the average daily outpatient volume of the local largest private hospital to plummet from 500 to 150 visits [5]

Institution Type	Loss Situation
Non-Public Hospitals	According to the 2021 National Health Statistics Yearbook, the overall loss in 2020 was RMB 130 billion [3]
Public Hospitals	Among the 2,508 tertiary public hospitals assessed in 2020, 43.5% were operating at a loss [3]
Closure Rate of Private Hospitals	Rose from 7.2% in 2023 to 19.6% in 2024 [6]
Closure Situation in 2025	1,247 private hospitals ceased operations in the first half of the year, with an average of 7 closing per day [6]

Hospital management has

[7]:

• Talent Bottleneck
  : High-quality medical resources are scarce, and private hospitals struggle to attract top-tier doctors
• Operational Complexity
  : Overlapping pressures from quality, brand, and market competition
• Strong Regional Attributes
  : Patient trust requires long-term accumulation
• Scarcity of Professional Management Teams
  : “It’s like finding a professional operation team for a five-star hotel” [7]

---

• 2012-2017
  : Hengkang Medical used high leverage to
  invest a total of RMB 4.3 billion and acquire 19 hospitals
  [8]
• 2015-2016
  : During the boom period of hospital M&A market, hospital valuations had a premium of 100%-200% [8]
• Outcome
  : Accumulated losses of over RMB 3.9 billion in two years; in 2020, it was issued a delisting risk warning by the CSRC, and its market value once shrank to RMB 3 billion (less than one-tenth of its peak) [8]
• Restructuring
  : New Milestone Hospital Group invested nearly RMB 2 billion in restructuring and took control of Hengkang Medical [8]

---

• BenQ Hospital
  : Operates only two general hospitals in Nanjing and Suzhou, adheres to no expansion, and has achieved profitability [9]
• Lianchi Hospital
  : Focuses on obstetrics and gynecology, has grown against the trend, and is preparing for a Hong Kong stock market listing [10]

Correct Logic for Medical Investment:
✓ Conform to market and industry rules
✓ Ensure cash flow stability
✓ Valuations must be reasonable
✓ Avoid investment decisions that violate business common sense
✓ Adopt long-termism mindset

Trend	Analysis
Increased Concentration	Large medical groups (such as New Milestone, China Resources Medical) acquire high-quality assets through restructuring [8]
Specialized Development	Consumer medical services (ophthalmology, dentistry, rehabilitation) and specialized hospitals have more advantages [5]
Compliant Operations	Medical insurance compliance and standardized internal management have become prerequisites for survival [4]
Silver Economy Opportunities	Rehabilitation and elderly care-related medical services may become new growth drivers [5]

---

The large-scale collapse of listed companies’ hospital investment frenzy is essentially

:

1. Short-term capital mindset
   cannot adapt to the
   long-cycle, heavy-asset, and professional
   characteristics of hospital operations
2. Fading policy dividends
   combined with
   demographic structure changes
   have accelerated industry consolidation
3. Extensive mergers and acquisitions
   have left a large number of “indigestible” hospital assets
4. Shortcomings in management capabilities
   have become the key crux of sustained losses

After this round of restructuring, medical investment will return to rationality:

, and only investors who truly understand medical industry rules and focus on value creation can survive in the industry.

---

[1] Xinhua Medical Hurries to Sell 11 Hospitals: 1-Yuan Sales, No Buyers Even at 90% Discount: The Collapse of Listed Companies’ Hospital Investment Frenzy - Sohu News (https://m.sohu.com/a/977949723_617205)

[2] Xinhua Medical Lists Hospital for Transfer: Losses Persist, Core Business Transformation Shows Results - Baidu Health (https://health.baidu.com/m/detail/ar_9566839695242474203)

[3] Hospital Closure Wave Begins - Investment World (https://news.pedaily.cn/202510/556213.shtml)

[4] RMB 1.84 Million Auction of Hospital Equity: Shaanxi Private Medical Group Struggles to Survive - Sina Finance (https://finance.sina.com.cn/roll/2025-07-30/doc-infifzss8307768.shtml)

[5] Rebirth Code Amid Closure Wave: How Private Hospitals Seize the Trillion-Yuan Silver Economy Market - ByDrug (https://bydrug.pharmcube.com/news/detail/5b641ccc41393abb0406184cd689ba3f)

[6] The First Private Medical Stock Comes Back to Life: Bubble, Bottom-Fishing, and the New Cycle of Medical Groups - Ailibi (https://www.ailibi.com/web/newsDetail?NEWS_ID=f80937ca348d49e599e20ac3197dfa21)

[7] Listed Companies Frequently Sell Hospitals: Capital Withdraws, Management Is Extremely Difficult - Sina Finance (http://finance.sina.com.cn/roll/2019-01-16/doc-ihqhqcis6527131.shtml)

[8] The First Private Medical Stock Comes Back to Life: Bubble, Bottom-Fishing, and the New Cycle of Medical Groups - Guangzhou Ailibi (https://www.ailibi.com/web/newsDetail?NEWS_ID=f80937ca348d49e599e20ac3197dfa21)

[9] Average Consultation Fee Exceeds RMB 1,000: Why Don’t High-End Private Hospitals Make Money? - Global Pharmaceutical Network (https://www.phirda.com/artilce_36814.html)

[10] Three Attempts at Capital Markets: A Hospital Specializing in Painless Childbirth Aims to Be “Shandong’s First Private Hospital Stock” - Sohu (https://m.sohu.com/a/978165126_564023)